{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:08:43Z","timestamp":1790118523320,"version":"4.0.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Vasopressin is reported to retain vasoconstrictive activity in the setting of acidemia, but preclinical models are inconsistent and studies have not evaluated the clinical effectiveness of vasopressin based on arterial pH. This study sought to determine the association between arterial pH and blood pressure after vasopressin initiation in septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>This retrospective, multicenter, observational cohort study evaluated the association of arterial pH at the time of vasopressin initiation with hemodynamic response to vasopressin and change in catecholamine dose after vasopressin initiation. Hemodynamic response was defined as a catecholamine dose decrease with mean arterial pressure greater than or equal to 65 mm Hg at 6 hours after vasopressin initiation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Patients from eight hospitals in a health system were evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients with septic shock initiated on vasopressin as a catecholamine adjunct between January 2012 and November 2017 were screened for inclusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>A total of 1,350 patients were included. At the time of vasopressin initiation patients were severely ill with arterial pH 7.28\u2009\u00b1\u20090.13, Sequential Organ Failure Assessment 14.1\u2009\u00b1\u20093.5, lactate 5.6\u2009\u00b1\u20094.6 mmol\/L, and norepinephrine-equivalent catecholamine dose 32.3\u2009\u00b1\u200925.4 \u00b5g\/min. After adjusting for lactate and Sequential Organ Failure Assessment with multivariable logistic regression, lower arterial pH was independently associated with lower odds of hemodynamic response to vasopressin (for each 0.1 unit arterial pH was below 7.40, response odds ratio 0.79; 95% CI, 0.72\u20130.87). For each 0.1 unit the pH was below 7.40 at vasopressin initiation, the norepinephrine-equivalent catecholamine dose increased by 1.5 \u00b5g\/min (95% CI, 0.5\u20132.5 \u00b5g\/min) at 1 hour, and increased by 2.5 \u00b5g\/min (95% CI, 1.4\u20133.5 \u00b5g\/min) at 6 hours after vasopressin initiation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Compared with higher arterial pH, patients with septic shock and low arterial pH had lower odds of vasopressin response and higher catecholamine doses after vasopressin initiation. Similar to other vasopressors, the clinical effectiveness of vasopressin appears to be impaired in the setting of acidemia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000634","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T17:27:34Z","timestamp":1644341254000},"page":"e0634","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study"],"prefix":"10.1097","volume":"4","author":[{"given":"Seth R.","family":"Bauer","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."},{"name":"Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen L.","family":"Sacha","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Siuba","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH."},{"name":"Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon W.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."},{"name":"Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita J.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH."},{"name":"Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Duggal","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH."},{"name":"Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidula","family":"Vachharajani","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH."},{"name":"Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH."},{"name":"Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"R1-20240807","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.2014.5804","article-title":"Hospital deaths in patients with sepsis from 2 independent cohorts.","volume":"312","author":"Liu","year":"2014","journal-title":"JAMA"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","article-title":"Frequency and mortality of septic shock in Europe and North America: A systematic review and meta-analysis.","volume":"23","author":"Vincent","year":"2019","journal-title":"Crit Care"},{"key":"R4-20240807","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock.","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock.","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMra1309483","article-title":"Lactic acidosis.","volume":"371","author":"Kraut","year":"2014","journal-title":"N Engl J Med"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/bja\/aen148","article-title":"Physiological effects of hyperchloraemia and acidosis.","volume":"101","author":"Handy","year":"2008","journal-title":"Br J Anaesth"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1590\/S0100-879X2008005000026","article-title":"Effects of acid-base imbalance on vascular reactivity.","volume":"41","author":"Celotto","year":"2008","journal-title":"Braz J Med Biol Res"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1378\/chest.33.1.18","article-title":"Depressed response to intravenous sympathicomimetic agents in humans during acidosis.","volume":"33","author":"Campbell","year":"1958","journal-title":"Dis Chest"},{"key":"R10-20240807","first-page":"437","article-title":"Vasopressor agents; influence of acidosis on cardiac and vascular responsiveness.","volume":"88","author":"Weil","year":"1958","journal-title":"Calif Med"},{"key":"R11-20240807","first-page":"E449","article-title":"Vasopressin in plasma and cerebrospinal fluid of dogs during hypoxia or acidosis.","volume":"247","author":"Wang","year":"1984","journal-title":"Am J Physiol"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.120.3.989","article-title":"Physiology of vasopressin relevant to management of septic shock.","volume":"120","author":"Holmes","year":"2001","journal-title":"Chest"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00134-004-2283-8","article-title":"Role of vasopressin in the management of septic shock.","volume":"30","author":"Mutlu","year":"2004","journal-title":"Intensive Care Med"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200363030-00001","article-title":"Management of vasodilatory shock: Defining the role of arginine vasopressin.","volume":"63","author":"Dunser","year":"2003","journal-title":"Drugs"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005344-199208000-00014","article-title":"Comparison of peptide and nonpeptide receptor-mediated responses in rat tail artery.","volume":"20","author":"Fox","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1213\/01.ane.0000290334.91624.2f","article-title":"The effects of extracellular pH on vasopressin inhibition of ATP-sensitive K+ channels in vascular smooth muscle cells.","volume":"105","author":"Kawano","year":"2007","journal-title":"Anesth Analg"},{"key":"R17-20240807","first-page":"F39","article-title":"Effects of extra- and intracellular pH on vascular action of arginine vasopressin.","volume":"260","author":"Okada","year":"1991","journal-title":"Am J Physiol"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin in adult patients with septic shock.","volume":"8","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R19-20240807","article-title":"Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock.","author":"Sacha","year":"2021 Sep 24","journal-title":"Crit Care Med"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2012.","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med"},{"key":"R23-20240807","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/emj.18.5.340","article-title":"Venous pH can safely replace arterial pH in the initial evaluation of patients in the emergency department.","volume":"18","author":"Kelly","year":"2001","journal-title":"Emerg Med J"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0736-4679(01)00431-0","article-title":"Venous pCO(2) and pH can be used to screen for significant hypercarbia in emergency patients with acute respiratory disease.","volume":"22","author":"Kelly","year":"2002","journal-title":"J Emerg Med"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2215\/CJN.00330109","article-title":"Agreement between central venous and arterial blood gas measurements in the intensive care unit.","volume":"5","author":"Treger","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJM198905183202004","article-title":"Assessing acid-base status in circulatory failure. Differences between arterial and central venous blood.","volume":"320","author":"Adrogu\u00e9","year":"1989","journal-title":"N Engl J Med"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/emj.2006.035915","article-title":"Agreement between arterial and central venous values for pH, bicarbonate, base excess, and lactate.","volume":"23","author":"Middleton","year":"2006","journal-title":"Emerg Med J"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00134-019-05837-1","article-title":"Characterization and validation of a novel measure of septic shock severity.","volume":"46","author":"Bosch","year":"2020","journal-title":"Intensive Care Med"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock.","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","article-title":"Vasopressor dose equivalence: A scoping review and suggested formula.","volume":"61","author":"Goradia","year":"2021","journal-title":"J Crit Care"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcrc.2018.05.003","article-title":"Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.","volume":"47","author":"Russell","year":"2018","journal-title":"J Crit Care"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/kisup.2011.32","article-title":"KDIGO Clinical practice guideline for acute kidney injury: Section 2: AKI definition.","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1513\/AnnalsATS.201808-564PS","article-title":"Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals.","volume":"16","author":"Lederer","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/sim.4780141510","article-title":"Graphical methods for assessing violations of the proportional hazards assumption in Cox regression.","volume":"14","author":"Hess","year":"1995","journal-title":"Stat Med"},{"key":"R36-20240807","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00134-009-1630-1","article-title":"Comparing two different arginine vasopressin doses in advanced vasodilatory shock: A randomized, controlled, open-label trial.","volume":"36","author":"Torgersen","year":"2010","journal-title":"Intensive Care Med"},{"key":"R37-20240807","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021.","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"R38-20240807","first-page":"H20","article-title":"Mechanism of diminished contractile response to catecholamines during acidosis.","volume":"254","author":"Marsh","year":"1988","journal-title":"Am J Physiol"},{"key":"R39-20240807","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock.","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"key":"R40-20240807","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1592\/phco.30.10.1057","article-title":"Arginine vasopressin for the treatment of septic shock in adults.","volume":"30","author":"Bauer","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R41-20240807","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1378\/chest.11-2604","article-title":"The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.","volume":"142","author":"Gordon","year":"2012","journal-title":"Chest"},{"key":"R42-20240807","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1172\/JCI112626","article-title":"Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.","volume":"78","author":"Arnolda","year":"1986","journal-title":"J Clin Invest"},{"key":"R43-20240807","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/cc6794","article-title":"Vasopressin impairs brain, heart and kidney perfusion: An experimental study in pigs after transient myocardial ischemia.","volume":"12","author":"M\u00fcller","year":"2008","journal-title":"Crit Care"},{"key":"R44-20240807","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13613-018-0406-6","article-title":"There is more to septic shock than arterial hypotension and elevated lactate levels: Another appeal to rethink current resuscitation strategies!","volume":"8","author":"D\u00fcnser","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R45-20240807","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ni.3398","article-title":"Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.","volume":"17","author":"Cheng","year":"2016","journal-title":"Nat Immunol"},{"key":"R46-20240807","first-page":"105","article-title":"Inflammatory cytokines stimulate glucose uptake and glycolysis but reduce glucose oxidation in human dermal fibroblasts in vitro.","volume":"37","author":"Taylor","year":"1992","journal-title":"Circ Shock"},{"key":"R47-20240807","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/SHK.0000000000000958","article-title":"Lactate and immunosuppression in sepsis.","volume":"49","author":"Nolt","year":"2018","journal-title":"Shock"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T14:32:12Z","timestamp":1723041132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000634","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}